Analysis Note

Specific Activity: Determined by its ability to induce osteoclast formation in RAW264.7 cells using a concentration range of 5.0-10.0 ng/mL.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Product Source: E. coli

Recombinant human sRANKL produced in E. coli. The protein is a 20.0 kDa polypeptide comprising the TNF homologous region of RANKL (176 amino acid residues).SEQUENCE: MEKAMVDGSW LDLAKRSKLE AQPFAHLTIN ATDIPSGSHK VSLSSWYHDR GWAKISNMTF SNGKLIVNQD GFYYLYANIC FRHHETSGDL ATEYLQLMVY VTKTSIKIPS SHTLMKGGST KYWSGNSEFH FYSINVGGFF KLRSGEEISI EVSNPSLLDP DQDATYFGAF KVRDID

COUNTRY OF ORIGIN: USA

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Physical form

Sterile filtered, and then lyophilized from 5 mM sodium phosphate, pH 7.6 + 75 mM NaCl. Reconstitute with distilled water to a concentration of 0.1-1 mg/mL as a stock solution. Solution can then be diluted into other aqueous buffers for immediate use.

Storage and Stability

The lyophilized powder is stable for several weeks at room temperature, but best stored at -20°C for up to one year from date of receipt. Reconstituted stock material can be stored at 2°-8°C for one week, but undiluted aliquots at -20°C are recommended for longer use. Avoid repeated freeze/thaw cycles.